Overview

Alefacept Mechanism of Action in Psoriasis

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
To determine the mechanism of action of alefacept in patients with psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborator:
Biogen
Treatments:
Alefacept